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tion between transmembrane HB-EGF and the exposedHeparin-binding epidermal growth factor-like growth factor is
glomerular basement membrane.expressed in the adhesive lesions of experimental focal glomer-
ular sclerosis.
Background. In this study, we attempted to determine
whether heparin-binding epidermal growth factor-like growth
The lesions of focal and segmental glomerular sclerosisfactor (HB-EGF) was up-regulated in two chronic models of
(FGS) arise as a consequence of several distinct patho-proteinuria.
Methods. Chronic passive Heymann nephritis (PHN) and logical processes, most notably in association with idio-
puromycin aminonucleoside (PAN) models were induced in pathic nephrotic syndrome or glomerular hyperfiltration
Sprague-Dawley rats. HB-EGF expression was studied by injury [1]. The lesion is characteristic and comprises ad-Northern blotting, in situ hybridization, and immunohisto-
hesion of a portion of the glomerular tuft to Bowman’schemistry.
capsule, with sclerosis of the adjacent glomerular capil-Results. The chronic PAN model was associated with the
development of glomerular lesions of focal glomerular sclerosis laries and deposition of hyaline material. In recent years,
(FGS), severe interstitial fibrosis, and renal failure. Lesions of Kriz et al have reported that the lesion of FGS com-
FGS were seen in approximately 80% of glomeruli at all time mences through the loss of visceral glomerular epithelial
points, with a slight increase in the number of glomeruli show-
cells (GECs), leaving bare the areas of the glomerularing extensive adhesion between 40 and 90 days. Northern blots
basement membrane (GBM) that adhere to parietal epi-of whole kidney tissue showed a 3- to 5.8-fold increased expres-
sion of HB-EGF mRNA in the chronic PAN group. Increased thelial cells of Bowman’s capsule [2, 3]. The stimulus to
mRNA and protein were localized by in situ hybridization and loss of these cells is suggested to be abortive mitogenesis,
immunohistochemistry to tubules, glomerular epithelial cells perhaps through the action of growth factors such as(GECs), and cells of Bowman’s capsule. HB-EGF mRNA and
fibroblast growth factor-2 (FGF-2).protein were strongly expressed by epithelial cells involved in
Heparin-binding epidermal growth factor-like growththe formation of the lesions of FGS. By contrast, in chronic
PHN, there was a small increase in HB-EGF, and the extensive factor (HB-EGF) is a potent fibroblast, epithelial, and
lesions of FGS did not develop despite continued, heavy pro- vascular smooth muscle cell mitogen [4]. It is synthesized
teinuria. in vitro by a variety of cell types, including macrophages,Conclusions. These data suggest that HB-EGF may contrib-
endothelial cells, and some epithelial cells [5]. Structur-ute to formation of the lesions of FGS, perhaps through stimu-
ally, HB-EGF is synthesized as a 27 kDa transmembranelation of abortive mitogenesis in GECs or an adhesive interac-
precursor that is lysed to produce a soluble 21 to 23 kDa
molecule that binds to heparan sulfate proteoglycans.
1 Current address: Department of Medicine, Renal Unit, Flinders Transmembrane HB-EGF is able to signal in a juxtacrineMedical Centre, Bedford Park, South Australia 5042, Australia.
manner through the EGF receptor, whereas the secreted2 Current address: Department of Nephrology, Royal Hobart Hospi-
tal, Hobart, Tasmania 7000, Australia. form is responsible for paracrine stimulation [5]. The
functions of HB-EGF, apart from mitogenesis, include
Key words: glomerulosclerosis, proteinuria, tubulointerstitial fibrosis,
cell adhesion and chemotaxis [6–8], as well as protectioninterstitial cells, podocytes, idiopathic nephrotic syndrome, hyperfil-
tration injury. against apoptosis by the transmembrane form [8].
We have previously reported increased HB-EGFReceived for publication August 1, 1998
mRNA and protein synthesis by GECs in two acuteand in revised form January 14, 1999
Accepted for publication January 18, 1998 models of proteinuria: the acute puromycin aminonucle-
oside (PAN) and passive Heymann nephritis (PHN) 1999 by the International Society of Nephrology
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models [9]. Because it appeared likely that the reported CA, USA). Creatinine was measured in serum and urine
samples by an Olympus A800 autoanalyzer.functions of HB-EGF could be important in the patho-
genesis of FGS, we have attempted to determine whether
Histological assessment of kidney sections for chronicHB-EGF is increased in two chronic models of protein-
tubulointerstitial fibrosisuria, one associated with FGS and the other not.
Tissue blocks were immersion fixed in 4% paraformal-
dehyde and were embedded in paraffin. Four mm sections
METHODS were cut on a microtome and were stained with periodic
Establishing the models acid-Schiff stain by standard methods. Sections were as-
sessed for tubulointerstitial fibrosis by the semiquantita-Male Sprague-Dawley rats were obtained from Mon-
tive method of Roy-Chaudhury et al [13]. Briefly, theash Medical Center, Clayton, Victoria, Australia, and
sections were first inspected in a blinded fashion andwere kept in the Animal Facility at St. Vincent’s Hospi-
then scored on an arbitrary scale of 0 to 3, dependingtal. They were given access to water and chow ad libitum.
on the degree of tubular atrophy and interstitial fibrosis.Urine was collected in metabolic cages, and blood for
Scores were 0, no change; 0.5, minor changes; 11, mild;laboratory estimations was obtained by tail bleeding un-
21, moderate; and 31, severe.der barbiturate anesthesia. All experiments were ap-
proved by the Animal Ethics Committee of St. Vincent’s Immunohistochemical staining for heparin-binding
Hospital. epidermal growth factor-like growth factor
Chronic PAN nephrosis. Chronic PAN was first de-
Immunohistochemical staining for HB-EGF was per-scribed by Glasser, Velosa, and Michael [10, 11]. In this
formed as recently described [9]. Tissue blocks werestudy, a modified model [12] was used. Three groups of
immersion fixed in 4% paraformaldehyde and were em-eight Sprague-Dawley rats (150 to 200 g) were used for
bedded in paraffin. Four-micrometer thick paraffin sec-the test groups. On day 0, the test groups were given an
tions were cut on a microtome and were dried overnightintraperitoneal injection of PAN (Sigma Chemical Co.,
at 378C. Sections were dewaxed and treated with 0.1%St. Louis, MO, USA), 15 mg/100 g body wt in mouse
pronase E (Sigma) for six minutes at 378C. Endogenoustonicity phosphate-buffered saline (MTPBS). A right-
peroxidase activity was inhibited using 3% hydrogen per-sided unilateral nephrectomy was performed by flank
oxide for 10 minutes. Sections were then blocked withincision on one of the ensuing four days. PAN was then
sheep serum (GIBCO BRL, Life Technologies, Gaith-
administered intraperitoneally at 4.3 mg/100 g body wt ersburg, MD, USA) for 30 minutes and incubated over-
during weeks 3, 4, and 5 after the initial dose of puromy- night at 48C with rabbit anti–HB-EGF antibody in 0.5 m
cin. Three groups of six Sprague-Dawley rats were used NaCl. Two rabbit anti–HB-EGF polyclonal antibodies
as controls. They were injected intraperitoneally with were used that have recently been described [9]. R847
MTPBS at the same time as the test groups and under- was produced by immunization with recombinant human
went right unilateral nephrectomy. Rats from control HB-EGF and was used as an affinity-purified immuno-
and test groups were sacrificed at 40, 60, and 90 days. globulin (Ig) preparation at 10 mg/ml, whereas R866 was
Tissues were snap frozen for isolation of RNA, and kid- produced against a synthetic peptide from rat HB-EGF,
ney blocks from all rats were processed for histology, in and it was used as an antiserum diluted at 1/250. The
situ hybridization, and immunohistochemical staining. negative controls used were normal rabbit Ig (Dako Cor-
Chronic PHN. PHN was induced in 150 to 200 g poration, Carpinteria, CA, USA) at 10 mg/ml or diluted
Sprague-Dawley rats using a protocol of two 0.6 ml injec- normal rabbit serum. Similar staining was obtained with
tions of anti-Fx1A over two days [9]. The test population both antibodies. Rabbit Ig was detected using a triple
was comprised of three groups of eight rats. Three groups layer technique, comprising monoclonal mouse antirab-
of four rats were injected with ammonium sulfate-cut bit Ig diluted at 1/50 (Dako) followed by biotinylated
sheep serum as controls. Both control and chronic PHN sheep antimouse Ig diluted at 1/200 (Amersham, Life
groups were sacrificed at days 40, 60, and 90 after disease Sciences, Buckinghamshire, UK), and streptavidin-con-
induction. Tissues were snap frozen for isolation of jugated horseradish peroxidase (Dako) diluted at 1/300,
RNA, and kidney blocks were processed for histology, each for 30 minutes, with washing steps between incuba-
in situ hybridization, and immunohistochemical staining. tions. Sections were developed using nickel-enhanced
diaminobenzidene (DAB; Pierce, Rockford, IL, USA)
Determination of proteinuria and creatinine clearance and counterstained with hematoxylin.
Rats were placed in metabolic cages for 16 hours over-
Detection of proliferating cells usingnight, and urine was collected. At the end of the collec-
bromodeoxyuridine incorporationtion period, blood was obtained by tail bleeding. Urine
was centrifuged to remove debris, and proteinuria was Bromodeoxyuridine (BrdU) is a pyrimidine analogue
of thymidine and is selectively incorporated into cellularassayed by a modified Lowry assay (Bio-Rad, Hercules,
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DNA at the S phase of the cell cycle [14]. It was used ity was blocked, and sections were incubated in normal
rabbit serum (Life Technologies) for 20 minutes. Sec-as a histological marker of cell proliferation. BrdU was
administered intraperitoneally to the animals three hours tions were incubated with appropriate dilutions of mono-
clonal antibody for one to two hours at room tempera-prior to sacrifice at a dose of 50 mg/g body wt. Renal
tissue was fixed in mercuric formalin. Four mm sections ture. Sections were then rinsed and incubated with rabbit
antimouse Ig (Dako) 1/50 for 20 minutes followed bywere dewaxed and rehydrated through graded alcohols.
Mercury pigment was removed by immersion in 2% io- mouse peroxidase-antiperoxidase complex (PAP; Dako)
diluted 1/100. DAB (Pierce) was used as the chromogen.dine in ethanol (5 min) and cleared with 5% sodium
thiosulfate (5 min). Sections were then quenched in 3%
Detection of heparin-binding epidermal growth factor-hydrogen peroxide and washed, and following this, DNA
like growth factor mRNA by in situ hybridizationwas denatured by immersion in 2 m hydrochloric acid
(HCl) for 30 minutes at 378C. Sections were then blocked A rat HB-EGF cDNA probe corresponding to posi-
tions 231 to 726, respectively, in the published sequencewith normal horse serum (Vector Laboratories, Burl-
ingame, CA, USA) for 20 minutes and then incubated of rat cDNA [19] was used to perform in situ hybridiza-
tion as previously described [20]. Briefly, a 496 bp cDNAwith monoclonal anti-BrdU (Sigma) diluted 1/1000 for
one to two hours at 378C. The Vectastain ABC Elite kit fragment was subcloned into the multiple cloning site of
the plasmid pGEM-T (Promega, Madison, WI, USA)protocol (Vector Laboratories) was used to detect the
monoclonal antibody. Sections were then washed, color between the SP6 and T7 promoters and was used to
produce DIG-labeled riboprobes. In situ hybridizationdeveloped with DAB (Pierce), counterstained, and cover
slipped. Irrelevant mouse Ig was used as a negative con- was performed by detection of DIG-labeled riboprobes
in paraformaldehyde-fixed tissue using kits obtainedtrol. BrdU-positive cells were determined by a blinded
observer who counted tubular cells in 10 high-power from Boehringer Mannheim. Antisense and sense ribo-
probes were used for each block studied. Sections werefields (HPF; 3100 magnification). A mean value was
then derived for each section. The overall group mean 6 counterstained with Nuclear Fast Red. Tissue obtained
from each of three rats was stained and examined atsd was calculated using sections from three to five kid-
neys. each time point.
For BrdU staining of tissue fixed in paraformaldehyde
Northern blots(required for staining of sequential sections for HB-EGF
and BrdU), the sections were microwaved (on medium) RNA was extracted from snap-frozen, whole kidney
cortex using Trizol (GIBCO BRL) according to the man-in 5 mm citrate buffer (pH 6.0) for 10 minutes. After
washing, they were incubated in 1 mg/ml trypsin (Sigma) ufacturer’s instructions. RNA samples were separated
on a 1% agarose gel with formaldehyde, transferred toat 378C for 30 minutes, washed again, and then incubated
with 3% hydrogen peroxide (BDH, Chemicals, Poole, a Genescreen Plus nylon membrane (NEN Life Sciences
Products, Boston, MA, USA), and hybridized to radiola-Dorset, UK) for 10 minutes. Sections were blocked with
10% sheep serum (Silenus, Melbourne, Australia) and beled cDNA probes. The probes used were the pre-
viously described 496 bp fragment of rat HB-EGF cDNAthen incubated overnight at 48C with FITC-conjugated
antihuman BrdU (PharMingen, San Diego, CA, USA). and a 1.2 kb fragment of mouse GAPDH. cDNA probes
were labeled using the Megaprime DNA Labeling Sys-After washing, they were incubated with peroxidase-
conjugated sheep antifluorescein (1/300) for 30 minutes. tem (Amersham) and hybridized using Rapid-hyb buffer
(Amersham). Membranes were washed and then ex-Peroxidase labeling was revealed using the liquid DAB
substrate-chromogen system (Dako). Sections were posed to film. Results were quantitated by densitometry
(Molecular Dynamics Computing Densitometer, Modelcounterstained with hematoxylin.
300A) using ImageQuant Software (version 3.0) and ra-
Immunohistochemical staining for macrophages and tios of HB-EGF/GAPDH calculated for each blot.
a-smooth muscle actin
StatisticsMacrophages were detected using ED-1 hybridoma
supernatant (a generous gift of Dr. Peter Tipping, Mon- Statistics were performed using the Instat software
package (version 2.01) from GraphPad Software. Allash Medical Center, Clayton, Victoria, Australia) diluted
at 1/50 [15]. The mAb, IA4, directed against a-smooth except one of the multiple comparisons were performed
using analysis of variance, followed by the Tukey-muscle actin (a-SMA; Dako) [16], and diluted 1/400, was
used as a marker of mesangial cell activation and for Kramer multiple comparison test. A P value of less than
0.05 was considered significant. For data that did notthe detection of myofibroblasts [17, 18]. Sections were
prepared as previously described. The microwaving tech- appear to be normally distributed, the Kruskall-Wallis
nonparametric analysis of variance was performed, fol-nique was employed for exposure of antigen in tissue
sections stained for ED-1. Endogenous peroxidase activ- lowed by Dunn’s multiple comparison test.
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Table 2. (A) Creatinine clearance in rats with chronic passiveTable 1. (A) Twenty-four hour urinary proteinuria in rats with
chronic passive Heymann nephritis (PHN) and their controls Heymann nephritis (PHN) and their controls
Day PHN ControlDay PHN Control
40 265.86106.3 7.663.4 40 1.0360.3 1.7960.06
(N 5 5) (N 5 4)(N 5 6) (N 5 3)
60 102.0612.3 3.361.6 60 1.5060.25 1.4460.28
(N 5 6) (N 5 4)(N 5 6) (N 5 3)
90 87.4630.6 4.762.4 90 1.6160.26 1.5060.38
(N 5 3) (N 5 3)(N 5 6) (N 5 3)
(B) Creatinine clearance in rats with chronic puromycin(B) Twenty-four hour urinary protein in rats with chronic puromycin
aminonucleoside nephrosis (PAN) and their controls aminonucleoside nephrosis (PAN) and their controls
Day PAN ControlDay PAN Control
40 631.06225.3 7.360.9 40 0.5460.22 1.3660.17
(N 5 4) (N 5 2)(N 5 5) (N 5 2)
60 253.3698.8 3.361.7 60 0.5960.38 1.2260.62
(N 5 6) (N 5 3)(N 5 6) (N 5 3)
90 275.8660.5 3.862.6 90 0.5360.28 1.2860.12
(N 5 5) (N 5 3)(N 5 6) (N 5 3)
Results are expressed as mean 6 sd of creatinine clearance in ml/second.Results are expressed as mean 6 sd of urinary protein in mg/24 hr.
stitial fibrosis were seen at day 40 (mean score 1 on anRESULTS
arbitrary scale of 0 to 3), and these progressed over theDescription of the models
course of the studies until the mean score was 2.3 6 1.0Proteinuria and creatinine clearance. All diseased rats
(Fig. 2B). These changes were predominantly tubularhad significant proteinuria (Table 1). This was more
dilation, interstitial fibrosis, and leukocyte infiltrationmarked in the chronic PAN group of rats, which also
(Fig. 1c). Again, there were no significant differences indeveloped gross ascites. PHN rats did not develop asci-
the degree of tubulointerstitial fibrosis at days 40, 60, ortes. Proteinuria was significantly greater in chronic PAN
90 in the chronic PAN model. At only day 90 was therats at day 40 when compared with PHN rats (P , 0.001)
score significantly different from controls (P , 0.05,but not at other time points. Creatinine clearance was
Dunn’s multiple comparison test).used as a measure of renal function (Table 2). In the
Immunohistochemistry for proliferating cells. BrdUchronic PHN group, there was no significant change in
staining was used to localize proliferating cells. In thecreatinine clearance compared with controls; however,
controls, staining was detected in the occasional tubularin the chronic PAN group, there was a decrease in creati-
epithelial cell (0.5 6 0.1 cells/HPF). The chronic PANnine clearance at all time points (P , 0.05).
group studied at day 40 contained the greatest numberHistological changes. In the PHN rats, there were al-
of proliferating cells (Figs. 2C and 3a). The majority ofmost no changes of tubulointerstitial fibrosis or focal
these cells were epithelial cells of dilated tubules. Theglomerular sclerosis (FGS; Fig. 1a), apart from occa-
number of proliferating cells at day 40 in the chronicsional peritubular foci of leukocyte infiltration (not
PAN model was significantly greater than at day 60 orshown). By contrast, there were extensive lesions of FGS
90 (P , 0.001). Moreover, at days 40 (P , 0.001), 60within the glomeruli at all time points (days 40, 60, and
(P , 0.001), and 90 (P , 0.01), the number of proliferat-90) in the chronic PAN model (Fig. 1 b–d). These were
ing cells was significantly greater than in normal kidneysscored by a blinded observer, and over 80% of the glo-
(P , 0.001). Glomerular staining was minimal, althoughmeruli showed histological lesions of FGS at day 40 (Fig.
very occasional glomeruli (approximately 10%) showed2A). Over the ensuing 50 days, there was an increase in
incorporation of BrdU by GECs and cells of Bowman’sthe percentage of glomeruli that showed a lesion involv-
capsule (Fig. 3b). The PHN group showed similar num-ing of more than 25% (Fig. 1b) of the circumference of
bers of positive cells to the controls (data not shown).Bowman’s capsule, but approximately 20% of glomeruli
a-smooth muscle actin expression. In the chronic PANdid not show lesions of FGS even at these later time
group, there was a marked difference in staining forpoints (Fig. 2A). There were no significant differences
a-SMA compared with the chronic PHN and controlbetween the percentage of glomeruli containing FGS
rats. Staining in the controls was, as expected, confinedlesions at days 40, 60, or 90 in the chronic PAN model.
to smooth muscle cells of the afferent and efferent arteri-However, the increase in FGS lesions was highly signifi-
oles and to medium-sized arterioles in the renal cortexcant at all time points compared with normal (P , 0.001).
In the tubulointerstitium, changes of chronic tubulointer- (similar to Fig. 3c). There was no staining observed in
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Fig. 1. PAS staining of paraformaldehyde-fixed sections. (a) Passive Heymann nephritis at day 90. The kidney shows normal histology at this
magnification (362.5). (b) Chronic PAN at day 90. A glomerulus showing an extensive FGS lesion, together with an interstitial infiltrate and
interstitial fibrosis is shown (362.4). (c) Chronic PAN day 40, showing extensive tubular dilation, glomeruli with FGS, and interstitial fibrosis
(331.2). (d) Chronic PAN at day 40, showing extensive adhesions between the glomerulus and Bowman’s capsule (3150).
the glomeruli or the interstitium. In contrast, kidneys the chronic PAN rats. Staining was marked in areas
of dense cellular infiltration, as well as in areas rich infrom the chronic PAN rats showed striking staining in
areas surrounding the capsule of abnormal glomeruli proliferating tubules, and appeared to surround glomer-
uli that were in various stages of fibrosis. Macrophage(Fig. 3d). These glomeruli typically showed signs of vari-
ous stages of sclerosis and fibrosis, with adhesions of staining was also observed in the tubular wall (Fig. 3e).
Glomerular staining for ED-11 macrophages was lessthe glomerular tuft and proliferation of epithelial and
Bowman’s capsule cells. Of interest was the pattern of dramatic than the interstitial staining. Scattered macro-
phages were observed in the glomeruli, mainly in capil-staining surrounding the glomeruli that were focally scle-
rosed. In these glomeruli, staining was restricted to the lary loops and occasionally in areas of glomerular adhe-
sion, fibrosis, and sclerosis (Fig. 3f). There was nofocally sclerosed area and was absent in the area sur-
rounding the normal-appearing Bowman’s capsule. In- demonstrable difference in staining in the day 40, 60,
and 90 groups.terstitial staining for a-SMA was observed surrounding
large hyperplastic, dilated tubules with hyaline casts, as Staining for ED-11 macrophages in the chronic PHN
group was less impressive (data not shown). The intersti-well as encircling small regenerating tubules. Staining
was less impressive in the chronic PHN group (Fig. 3c). tial infiltrate in the chronic PHN model was very patchy,
present only as occasional foci of peritubular inflamma-Overall, the glomeruli did not stain and were normal in
appearance. Proliferating tubules were surrounded by tion, and this was reflected in the staining for ED-11
cells. The macrophage appeared to be the predominantcells positive for a-SMA.
Macrophage infiltration. The ED-11 macrophage was cell of this patchy infiltrate. Overall, there was little stain-
ing of the glomeruli in this PHN group.the predominant cell in the tubulointerstitial infiltrate of
Paizis et al: HB-EGF in focal sclerosis 2315
no significant difference between the three time points.
In the chronic PHN rats, there was no significant differ-
ence compared with the nephrectomy specimens. There
was a trend toward an increased level at day 60.
In situ hybridization. The increase in HB-EGF
mRNA was confirmed by in situ hybridization, which
showed increased staining in both models compared with
controls (Fig. 5). In the PHN model, there was a moder-
ate increase in expression within GECs at day 60 (Fig.
5b) compared with controls (Fig. 5a). Cells of Bowman’s
capsule were occasionally positive. There was also a
slight, generalized increase in tubular epithelium. This
change was not sufficient, however, to be detected in the
Northern blots performed earlier. In the chronic PAN
model, the increase was much more obvious. There was
striking up-regulation in tubules at day 40 (Fig. 5d),
which continued to day 90 (Fig. 5c). This was particularly
localized to areas of proliferating tubular epithelial cells,
where multiple layers of epithelial cells lined the tubular
wall (Fig. 5c). GECs strongly expressed HB-EGF mRNA
at all time points, although it appeared to be greatest at
days 60 and 90, and there was also strong expression in
some cells of Bowman’s capsule (Fig. 5c). In the adhesive
lesions of FGS, there was very strong expression (Fig. 5
e, f), whether the lesion was localized (Fig. 5f) or exten-
sive (Fig. 5e). It was impossible in these lesions to deter-
mine whether the adhesive cell expressing HB-EGF
mRNA had originated from GECs or cells of Bowman’s
capsule. Sense controls showed no staining.
Immunohistochemical staining for heparin-binding
growth factor-like growth factor
Using a polyclonal anti–HB-EGF antibody, the distri-
Fig. 2. Morphological characteristics of the chronic PAN model at days bution of HB-EGF protein was similar to that of mRNA
40, 60, and 90 after induction. Symbols are: (h) normal; (j) FGS , seen by in situ hybridization (Fig. 6). Sections stained25%; ( ) FGS . 25%). (A) The percentage of glomeruli showing focal
with a negative control antibody showed no staining. Inglomerulosclerosis involving less than 25% or more than 25% of the
glomerular tuft circumference. (B) Semiquantitative assessment of the control kidneys, the distribution was the same as that
extent of tubulointerstitial fibrosis according to an arbitrary scale of 0 which has recently been described using the anti–HB-to 3. (C) Proliferating tubular cells expressed as the number per high
EGF antibody (Fig. 6a) [9]. In PHN, there was slightlypower fields (HPF; 3100). All results are expressed as mean 6 1 sd.
increased staining within the glomerulus in GECs and
by the brush border of proximal tubular cells at day 60
(Fig. 6b). Staining within the distal tubular cells and the
Expression of heparin-binding epidermal growth medullary and cortical segments of the loop of Henle
factor-like growth factor remained, however, the most impressive staining in these
sections and was unchanged from the controls. As oc-Northern blots. Northern blots of whole kidney RNA
from the chronic PAN rats showed increased HB-EGF curred with the in situ hybridization studies, expression
was much greater in the chronic PAN model. In themRNA, expressed as fold-increase of HB-EGF/GAPDH
ratios, compared with PHN kidneys at the same time glomerulus, expression occurred in GECs (Fig. 6c) and
in the cells of Bowman’s capsule (Fig. 6 c, d). Stainingpoint and the nephrectomy specimens (Fig. 4). At day
40, chronic PAN rats had a threefold induction compared in the GECs often had a granular appearance (Fig. 6
e, f). Within the lesions of FGS, there was increasedwith normal, and this increased to 5.8-fold at day 60 (P ,
0.01 compared with PHN at day 60), reducing slightly expression in cells of Bowman’s capsule (Fig. 6e) and
GECs (Fig. 6f). Tubular expression was also increasedat day 90 to 4.6-fold (P , 0.01 compared with PHN at
the same stage). Although the increase was greatest at in this model (Fig. 6 c, d). This was the most marked in
the dilated tubules or those containing more than oneday 60 postinduction in the chronic PAN rats, there was
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Fig. 3. Staining for BrdU-positive cells, ED-1, and a-smooth muscle actin. (a) Chronic PAN day 40, stained for BrdU incorporation. A number
of positive cells are seen in a dilated tubule in the middle of the field (arrow; 325). (b) Chronic PAN day 40, stained for BrdU incorporation. A
number of positive cells are seen in Bowman’s capsule (arrow) and in adjacent GECs of the capillary tuft (3125). (c) Passive Heymann nephritis
day 90, stained for a-smooth muscle actin. The appearances are indistinguishable from normal (350). (d) Chronic PAN day 90, stained for a-smooth
muscle actin. Increased staining is seen in peritubular and periglomerular areas and within the glomerulus itself (350). (e) Chronic PAN day 60,
stained for macrophages with the mAb ED-1. Macrophages can be seen within one tubular cross-section (arrow; 3125). ( f ) A section of chronic
PAN day 60 also stained with ED-1. Macrophage seen within the glomerulus (arrow; 3125).
layer of epithelial cells. There was no detectable staining EGF, sequential sections from chronic PAN kidneys at
day 40 were stained with anti–HB-EGF antibody or anti-of infiltrating cells in the interstitium or of fibroblast-
like cells. To determine whether the dilated tubules that BrdU antibody. This showed that virtually all of the
dilated tubules containing multiple BrdU-positive cellscontained multiple BrdU-positive cells expressed HB-
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Fig. 4. Northern blot analysis of whole kid-
ney RNA from rats with chronic puromycin
aminonucleoside (PAN) and passive Hey-
mann nephritis (PHN). (A) A representative
Northern blot probed with heparin binding-
epidermal growth factor (HB-EGF) cDNA
followed by GAPDH. Abbreviations used are
interpreted as follows: PHN 40, for example,
refers to results from rats with chronic PHN
at day 40 after induction. Similarly, PAN 40
refers to results from rats with chronic PAN
40 days after induction, and so on. Nx is RNA
from a nephrectomized control animal receiv-
ing saline. This control was performed to dem-
onstrate that unilateral nephrectomy does not
alter HB-EGF expression compared with kid-
neys from rats that have received no treat-
ment. (B) The fold-induction of HB-EGF/
GAPDH ratios, corrected within each of three
separate experiments by using values obtained
from a normal kidney as 1 (expressed as
mean 6 1 sd). Asterisks denote significance
values (P , 0.01 compared with PHN kidneys
at the same time point).
stained strongly for HB-EGF (Fig. 6 g, h). However, combined with repeated administration of PAN to pro-
duce severe proteinuria and renal failure, however, ex-approximately half of the tubular cross-sections that
pression of HB-EGF was strikingly different. Increasedstained strongly for HB-EGF did not contain BrdU-
expression in the chronic PAN model (which, it must bepositive cells. These were generally tubules of relatively
stressed, is not simply an earlier stage of the acute PANnormal diameter.
model because unilateral nephrectomy was performed)
occurred mainly in tubules, GECs, and cells of Bowman’s
DISCUSSION capsule.
This study has shown striking, chronic up-regulation Within the glomerulus, up-regulation of HB-EGF in
of HB-EGF mRNA and protein in one of two chronic the chronic PAN model was seen in both visceral GECs
models of proteinuria. We have previously reported up- and cells of Bowman’s capsule. One interesting feature
regulation of HB-EGF mRNA and HB-EGF protein in of the glomerular expression of HB-EGF was the strong
acute studies (less than 21-days postinduction) of the up-regulation seen in epithelial cells involved in the early
single-shot PAN and PHN models [9]. Increased expres- lesions of FGS, where capillary loops appeared to adhere
sion of HB-EGF protein and mRNA was noted, particu- to cells of Bowman’s capsule. In lesions that were more
larly in the visceral GECs of glomeruli. In the chronic well developed, cells bordering the lesion strongly ex-
PHN model, findings were very similar to those reported pressed HB-EGF.
There were two potential ways in which HB-EGFfor the acute model. Where unilateral nephrectomy was
Fig. 5. In situ hybridization for HB-EGF in sections from passive Heymann nephritis and chronic PAN. All sections probed with antisense HB-
EGF riboprobe. (a) A section from the chronic PAN control at day 40 showing faint tubular expression (3100). (b) Passive Heymann nephritis
day 40, showing staining in the GEC’s (arrow; 3100). (c) Chronic PAN day 90, showing intense staining in GEC’s (thin arrow) and some tubules
(thick arrow; 3100). (d) Chronic PAN day 40 showing strong expression in an FGS lesion (arrow; 350). (e) Chronic PAN day 40, with a part of
a glomerulus in the center of the section. The top of the glomerulus shows strong expression in cells at the center of an FGS lesion (arrow) and
in GECs bordering the lesion (3200). ( f ) Chronic PAN day 40, with a part of a glomerulus in the center of the section. The top of the glomerulus
shows expression in an early lesion of FGS (arrow; 3200).
c
Fig. 6. Immunohistochemical staining of sections with anti-HB-EGF antibody. (a) A section from chronic PAN controls showing expression in
tubules (3100). (b) Passive Heymann nephritis day 60, showing increased glomerular expression, predominantly in GECs, as well as an increase
in tubular staining (3100). (c) Chronic PAN day 60, showing an increase in staining in an FGS lesion (3100). (d) Chronic PAN day 60, showing
very prominent staining bordering an FGS lesion, following the line of Bowman’s capsule (3120). (e) Higher power view of a section from chronic
PAN day 90, with expression seen in a cell of Bowman’s capsule (arrow) and in cells of the glomerular tuft (3200). ( f ) Chronic PAN day 90,
showing staining of an adhesive lesion (arrow) and within the tuft (3200). Sections (g) and (h) are sequential. (g) Chronic PAN day 40 stained
with anti–HB-EGF antibody (362.5). (h) Sequential section stained for BrdU (362.5). Dilated tubules with a number of BrdU-positive cells are
indicated in both sections with a large star and a circled star. A tubule staining strongly for HB-EGF but with no BrdU-positive cells is marked
with a small star.
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could contribute to the development of FGS. First, HB- than HB-EGF alone, is likely to be important in the
pathogenesis of chronic tubulointerstitial fibrosis.EGF can stimulate proliferation of epithelial and mesen-
chymal cells by paracrine, autocrine, or juxtacrine
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